Study factors linked to ALS development
Part of Brain & nervous system clinical trials.
This study looks at people who might have amyotrophic lateral sclerosis (ALS) to understand what factors are associated with how the condition starts and develops. If you have a suspected or confirmed ALS diagnosis, it may help researchers learn what influences ALS and potentially guide future prevention or care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- A doctor must suspect, or say ALS is possible, probable, or definite
- You should be able to participate in study visits and assessments
- You may need to share information about your health history and symptoms
- There are no stated exclusion conditions in the provided details
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at genetic risk for amyotrophic lateral sclerosis (ALS) in families. It may help researchers understand who carries ALS-related gene changes and how that affects future care.
This study looks at the biology of amyotrophic lateral sclerosis (ALS) to better understand the disease. If you are a patient of Dr. Espíndola at UFSC, you may be able to join.
This study watches people with ALS over time to better understand how symptoms change and what features show up. It may help future care and treatments by improving doctors’ understanding of ALS’s natural course.
This study follows people living with amyotrophic lateral sclerosis (ALS) over time. It may help researchers better understand ALS and track changes that could guide future treatments.
This study looks at people affected by ALS (a nerve disease) and, in some cases, family members who may be at genetic risk. It may help researchers better understand ALS and related conditions and improve how they’re studied.
This study looks at genetic (inherited) factors in people with ALS. Your participation may help researchers better understand why ALS happens and who might be at risk.
Hear when a new ALS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.